Gaspar Taroncher-Oldenburg, PhD

Director, Therapeutics Alliances

Gaspar Taroncher-Oldenburg is the director of Therapeutics Alliances. A versatile innovation leader in biotech/biopharma with a knack for facilitating the transition of basic science to commercial implementation, Dr. Taroncher-Oldenburg was a consultant to Fortune 500 companies, academic and research institutions, and foundations worldwide for the past nine years. Prior to becoming a consultant, he was the founding and managing editor of Nature’s SciBX: Science-Business eXchange, a publication that bridged the translational divide by providing in-depth analysis of the scientific, clinical, and commercial context for the latest discoveries in the life sciences. Before launching SciBX in 2008, Dr. Taroncher-Oldenburg was a scientific editor of Nature Biotechnology and conducted research and taught at Princeton University, MIT, and Tufts University. Dr. Taroncher-Oldenburg holds a PhD from MIT and the Woods Hole Oceanographic Institution and a first degree in biology from the Universidad Autónoma in Madrid, Spain.

As director of Therapeutics Alliances, Dr. Taroncher-Oldenburg develops strategies to mobilize therapeutic innovation happening at NYU’s School of Medicine in close collaboration with the school’s faculty, other internal stakeholders, and external partners.